OBI — Ondine Biomedical Share News
0.000.00%
Last trade - 00:00- £55.85m
- £53.11m
- CA$2.05m
REG - Ondine Biomedical - Ondine Provides Update on US Phase 3 Pivotal Study
AnnouncementREG - Ondine Biomedical - Holdings in Company
AnnouncementREG - AIM - AIM Notice - 27/02/2026
AnnouncementREG - Ondine Biomedical - Share Issuance for ICU Study Submission
AnnouncementREG - Ondine Biomedical M&G PLC - Holding(s) in Company
AnnouncementRCS - Ondine Biomedical - Ondine and Mid Yorks Win National Award
AnnouncementRCS - Ondine Biomedical - Steriwave Up for 2025 “Product of the Year” Award
AnnouncementRCS - Ondine Biomedical - Expanding Steriwave Use Across Vancouver Island
AnnouncementRCS - Ondine Biomedical - Steriwave Expands into ENT Surgery in Spain
AnnouncementRCS - Ondine Biomedical - New Independent Study Supports Photodisinfection
AnnouncementRCS - Ondine Biomedical - Finalist for 2nd National Award for SSI reduction
AnnouncementREG - Ondine Biomedical - First German Hospital Pilots Steriwave
AnnouncementRCS - Ondine Biomedical - Ondine shortlisted for HSJ Partnership Award
AnnouncementREG - Ondine Biomedical - Topline Results Significant in Steriwave ICU Study
AnnouncementREG - Ondine Biomedical - Cambridge’s Papworth Hospital Pilots Steriwave
AnnouncementREG - Ondine Biomedical - Ondine Biomedical Continues Growth in H1 2025
AnnouncementRCS - Ondine Biomedical - Steriwave Now Protecting Patients with Cancer
AnnouncementREG - Ondine Biomedical - Notice of Interim Results & Investor Presentation
AnnouncementRCS - Ondine Biomedical - Ondine Presents Major Economic Benefits at ICPIC
Announcement